Reporting of Rurality, Deprivation, and Socioeconomic Characteristics in Cancer Clinical Trials: A Systematic - Report - MDSpire

Reporting of Rurality, Deprivation, and Socioeconomic Characteristics in Cancer Clinical Trials: A Systematic

  • By

  • Joseph M. Unger

  • June 23, 2026

  • 0 min

Share

Clinical Report: Assessment of Rurality, Socioeconomic Status, and Deprivation in Cancer Clinical Trials

Overview

This systematic review evaluates the reporting of geographic, socioeconomic, and demographic variables in randomized cancer clinical trials.

Background

Cancer outcomes in the US are influenced by geographic and socioeconomic factors, with patients from rural areas facing worse outcomes due to limited access to care. Area-level measures of socioeconomic deprivation correlate with poorer survival rates, even among those receiving standardized treatment in clinical trials.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • Patients from rural areas have worse cancer outcomes due to limited access to care.
  • Socioeconomic deprivation is linked to poorer survival rates in cancer clinical trials.
  • Prior studies indicate poor reporting of geographic and socioeconomic factors in clinical trials.

Clinical Implications

Improving the representation of diverse populations in cancer clinical trials is essential for accurate interpretation of treatment efficacy. Enhanced reporting of geographic and socioeconomic factors can inform better healthcare policies and practices.

Conclusion

This review underscores the importance of characterizing trial populations to improve the generalizability of cancer research findings. Addressing disparities in trial representation is critical for equitable cancer care.

Related Resources & Content

  1. Unger et al, ASCO Post, 2019 -- Socioeconomic Deprivation and Outcomes in Cancer Clinical Trials
  2. ASCO Post, 2023 -- Neighborhood Social Vulnerability and Its Influence on the Availability of Clinical Trials in Multiple Myeloma
  3. Frontiers in Oncology, 2026 -- Signals of inequity in the care pathway: rural lab diagnosis, systemic therapy delays, and RAS mutation differences in metastatic colorectal cancer
  4. FDA -- Conducting Clinical Trials With Decentralized Elements
  5. conexiant — Deprivation Tied to Lower HNC-Specific QOL
  6. Conducting Clinical Trials With Decentralized Elements | FDA
  7. Association of rurality status with all-cause and cancer-specific survival: a systematic review and meta-analysis adjusting for clinical factors, demographics, and geographical remoteness - PubMed
  8. Social Vulnerability Index | Place and Health - Geospatial Research, Analysis, and Services Program (GRASP) | ATSDR

Original Source(s)

Related Content